Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
NeutriSci International. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
NeutriSci International's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as NeutriSci International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Personal Products industry annual growth in earnings.
Earnings growth vs Low Risk Savings
expected to grow at an
Unable to compare NeutriSci International's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare NeutriSci International's earnings growth to the Canada market average as no estimate data is available.
Unable to compare NeutriSci International's revenue growth to the Canada market average as no estimate data is available.
Unable to determine if NeutriSci International is high growth as no earnings estimate data is available.
Unable to determine if NeutriSci International is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
All data from NeutriSci International Company Filings, last reported 6 months ago, and in
Trailing twelve months (TTM)
annual period rather than quarterly.
TSXV:NU Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions)
Net Income *
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
It is difficult to establish if NeutriSci International has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
It is difficult to establish if NeutriSci International has efficiently used its assets last year compared to the North America Personal Products industry average (Return on Assets) as it is loss-making.
It is difficult to establish if NeutriSci International improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
NeutriSci International's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
A company's financial position is much like your own financial position,
it includes everything you own
The boxes below represent the relative size of what makes up
NeutriSci International's finances.
The net worth of a company is the difference between its assets and liabilities.
NeutriSci International is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
NeutriSci International has no long term commitments.
This treemap shows a more detailed breakdown of
NeutriSci International's finances. If any of them are yellow this
indicates they may be out of proportion and red means they relate to one of the
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
High level of physical assets or inventory.
NeutriSci International has no debt, it does not need to be covered by short term assets.
Nearly all companies have debt. Debt in itself isn’t
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.
The graphic below shows equity (available funds) and debt, we ideally want to
see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and
whether the level has increased over the past 5 years.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Mr. Glen Rehman has been the Chief Executive Officer of NeutriSci International Inc. since December 2017 and is its President since November 26, 2014. Mr. Rehman served as the President of NeutriSci International Inc. since November 26, 2014. Mr. Rehman served as Chief Operating Officer of NeutriSci International Inc. and has been its a Director since November 26, 2014.
Glen's compensation has increased whilst company is loss making.
Glen's remuneration is about average for companies of similar size in Canada.
CEO, President & Director
Chief Financial Officer
Vice President of Sales & Marketing
Board of Directors Tenure
Average tenure of the
board of directors in years:
The tenure for the NeutriSci International board of directors is about average.
Board of Directors
CEO, President & Director
Who owns this company?
Recent Insider Trading
No 3 month open market individual insider trading information.
Will You Be Burnt By NeutriSci International Inc's (CVE:NU) Cash Burn?
As the CA$10.00m market cap NeutriSci International Inc (CVE:NU) released another year of negative earnings, investors may be on edge waiting for breakeven. … Additional cash raising may dilute the value of your shares, and since NeutriSci International is currently burning more cash than it is making, it’s likely the business will need funding for future growth. … NeutriSci International may need to come to market again, but the question is, when?
Who Are The Top Investors In NeutriSci International Inc (CVE:NU)?
Check out our latest analysis for NeutriSci International TSXV:NU Ownership_summary Apr 13th 18 Insider Ownership Another important group of shareholders are company insiders. … This size of ownership gives retail investors collective power in deciding on major policy decisions such as executive compensation, appointment of directors and acquisitions of businesses. … Private Company Ownership Potential investors in NU should also look at another important group of investors: private companies, with a stake of 0.64%, who are primarily invested because of strategic and capital gain interests.
One Thing To Consider Before Buying NeutriSci International Inc (TSXV:NU)
A popular measure of market risk for a stock is its beta, and the market as a whole represents a beta value of one. … See our latest analysis for NU An interpretation of NU's beta NeutriSci International has a beta of 3.71, which means that the percentage change in its stock value will be higher than the entire market in times of booms and busts. … NU, with its market capitalisation of CAD CA$8.27M, is a small-cap stock, which generally have higher beta than similar companies of larger size.
When Will NeutriSci International Inc (TSXV:NU) Need To Raise More Money?
The single most important question to ask when you’re investing in a loss-making company is – will they need to raise cash again, and if so, when? … Companies with high cash burn rates can eventually turn into ashes, which makes it the biggest risk an investor in loss-making companies face. … The cash burn analysis result indicates a cash constraint for NU, due to its high opex growth and its level of cash reserves.
NeutriSci International Inc. develops, markets, and distributes nutraceutical products in Canada. Its products include Neuenergy, an energy chewable tablet that provides focus and mental clarity; and BluScience, a nutraceutical product. The company sells its products through a distribution network of retail and online channels. NeutriSci International Inc. has partnership with Cryopharm Corporation. NeutriSci International Inc. was founded in 2009 and is headquartered in Calgary, Canada.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.